≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Monoplegia

DOID EFO Endpoint Browser PheWeb

G6_MONOPLE

cycloplegia: Cycloplegia is paralysis of the ciliary muscle of the eye, resulting in a loss of accommodation.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

538

4. Check minimum number of events

None

538

5. Include endpoints

None

538

6. Filter based on genotype QC (FinnGen only)

538

Control definitions (FinnGen only)

Control exclude
G6_CPETAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3782 1832 1917
Only index persons 3338 1651 1687
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.05
Only index persons 0.06 0.06 0.06
Median age at first event (years)
Whole population 57.60 56.77 58.25
Only index persons 56.05 55.02 57.06

-FinnGen-

Key figures

All Female Male
Number of individuals 538 304 234
Unadjusted period prevalence (%) 0.10 0.10 0.10
Median age at first event (years) 57.25 54.08 61.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
477
Matched controls
4767
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G83.1
ICD-10 Finland
Monoplegia of lower limb
4725.2
257.6
225
*
G83.2
ICD-10 Finland
Monoplegia of upper limb
+∞
206.8
183
*
G83.3
ICD-10 Finland
Monoplegia, unspecified
+∞
86.1
80
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
37.0
35
*
TAB00
NOMESCO Finland
Lumbar puncture
10.4
32.3
65
71
AA1AD
NOMESCO Finland
CT of head and brain
3.6
31.6
181
692
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
5.1
29.7
102
240
Z3226
NOMESCO Finland
Physiotherapist
3.6
26.5
144
515
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.7
25.7
68
115
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.9
25.0
117
368
N02AX02
ATC
tramadol; systemic, rectal
2.8
24.6
259
1436
R4110
NOMESCO Finland
Physiotherapy
3.0
24.2
182
816
N03AX12
ATC
gabapentin; oral
3.6
24.1
125
427
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.8
22.7
81
195
N03AX16
ATC
pregabalin; oral
2.9
21.7
169
763
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.5
21.1
80
205
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.1
20.7
87
246
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
20.6
127
486
L28
ICPC
Limited function/disability (L)
3.3
19.2
111
405
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.4
18.5
71
183
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.3
18.5
58
121
Z2446
NOMESCO Finland
Social worker
4.8
17.6
61
142
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
17.4
173
878
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
14.0
17.2
29
22
Z3231
NOMESCO Finland
Registered nurse
2.5
17.1
168
848
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
16.8
109
428
R4120
NOMESCO Finland
Occupational therapy
4.4
16.8
63
159
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
6.3
16.6
45
78
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
17.5
16.2
25
15
M54.5
ICD-10 Finland
Low back pain
2.4
16.1
190
1044
R20.2
ICD-10 Finland
Paraesthesia of skin
4.7
15.9
56
132
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
15.8
103
403
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
15.7
15
*
R51.80
ICD-10 Finland
Headache
2.9
15.4
102
404
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
15.4
93
344
N03AE01
ATC
clonazepam; systemic
4.6
15.3
54
128
M03BX01
ATC
baclofen; systemic
10.6
15.2
29
29
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.6
15.0
70
215
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
14.3
63
184
N02AA05
ATC
oxycodone; systemic
2.9
14.1
97
390
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.1
14.1
56
149
M54.4
ICD-10 Finland
Lumbago with sciatica
2.7
13.9
105
446
ZXD35
NOMESCO Finland
Usual procedure
5.8
13.5
38
70
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
21.9
13.4
19
9
R1250
NOMESCO Finland
Evaluation of functional capability
8.9
12.9
27
32
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.6
12.8
45
106
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
12.7
101
443
M54.1
ICD-10 Finland
Radiculopathy
5.5
12.6
37
72
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.4
12.4
45
110
M79.6
ICD-10 Finland
Pain in limb
2.1
12.4
193
1168
A28
ICPC
Limited function/disability NOS
2.7
12.4
91
381
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
12.3
54
157
Z2221
NOMESCO Finland
Medical doctor
2.2
12.1
154
853
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
11.8
97
432
N06AX21
ATC
duloxetine; oral
3.1
11.7
69
249
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
11.6
122
616
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
11.5
86
361
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
11.4
74
287
N18
ICPC
Paralysis/weakness
9.2
11.4
23
26
N06AX11
ATC
mirtazapine; oral
2.1
11.3
165
962
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
11.3
116
579
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
11.2
145
805
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
10.4
11.1
21
21
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.5
11.0
52
161
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
11.0
55
178
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
6.7
11.0
27
42
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
10.9
56
185
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.9
10.9
69
261
WX892
NOMESCO Finland
Monitored bed care
3.4
10.9
54
174
R06.0
ICD-10 Finland
Dyspnoea
2.2
10.9
136
744
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
10.7
219
1453
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.7
10.5
35
79
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
10.4
200
1293
ZXD05
NOMESCO Finland
Urgent procedure
2.0
10.3
163
976
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
10.1
189
1206
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
9.9
226
1545
N06AX16
ATC
venlafaxine; oral
2.5
9.8
80
354
N05AH04
ATC
quetiapine; oral
2.4
9.7
93
444
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.3
9.7
29
58
B01AB05
ATC
enoxaparin; parenteral
2.0
9.7
160
970
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.7
9.4
41
119
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
9.4
9
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
5.6
9.2
26
49
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
9.1
52
185
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.1
115
626
ZX120
NOMESCO Finland
Intravenous
2.9
9.0
56
211
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
9.0
128
731
L17
ICPC
Foot/toe symptom/complaint
2.0
8.9
134
781
Z71.8
ICD-10 Finland
Other specified counselling
2.0
8.9
121
679
G35
ICD-10 Finland
Multiple sclerosis
11.0
8.8
16
15
XKD06
NOMESCO Finland
Physiologic investigation of micturition
5.0
8.8
27
56
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.3
8.8
31
75
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.7
177
1146
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
8.6
95
487
G44.2
ICD-10 Finland
Tension-type headache
2.4
8.5
76
349
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.0
8.5
26
54
J01MA02
ATC
ciprofloxacin; systemic
1.8
8.4
197
1336
M48.0
ICD-10 Finland
Spinal stenosis
2.4
8.4
73
331
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.4
8.4
40
126
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
8.4
95
492
SPAT1229
SPAT
Assessment of need for aid
2.9
8.3
51
188
X57
ICD-10 Finland
Unspecified privation
6.7
8.3
20
31
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
8.2
70
315
Z2445
NOMESCO Finland
Psychologist
4.3
8.2
29
70
C03CA01
ATC
furosemide; systemic
1.9
8.2
140
849
S06.0
ICD-10 Finland
Concussion
2.7
8.2
58
235
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.4
8.2
38
117
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
12.0
8.1
14
12
RS220
NOMESCO Finland
NA
10.3
8.1
15
15
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
8.0
80
390
WX110
NOMESCO Finland
Local anesthesy
1.8
8.0
321
2560
N03AX11
ATC
topiramate; oral
5.6
7.9
22
41
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
7.9
144
895
C07AB07
ATC
bisoprolol; oral
1.7
7.9
220
1568
H02AB06
ATC
prednisolone; systemic
1.7
7.8
224
1608
N28
ICPC
Limited function/disability (N)
6.1
7.8
20
34
N05BA01
ATC
diazepam; systemic, rectal
2.3
7.7
76
369
G56.2
ICD-10 Finland
Lesion of ulnar nerve
4.4
7.6
26
61
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.9
7.6
20
35
N17
ICPC
Vertigo/dizziness
2.5
7.6
60
259
L86
ICPC
Back syndrome with radiating pain
3.2
7.5
38
125
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
7.5
111
636
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
7.5
175
1177
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
7.4
43
156
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.2
7.3
37
122
ZY010
NOMESCO Finland
Hospital outpatient
3.7
7.3
31
89
M54.2
ICD-10 Finland
Cervicalgia
2.9
7.3
44
164
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
7.3
57
247
N03AX09
ATC
lamotrigine; oral
3.6
7.2
31
90
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.1
7.2
38
129
R20.1
ICD-10 Finland
Hypoaesthesia of skin
30.5
7.2
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.2
115
681
N86
ICPC
Multiple sclerosis
20.4
7.2
10
5
X58
ICD-10 Finland
Exposure to other specified factors
2.2
7.1
74
366
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
7.1
65
303
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
7.1
40
141
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
4.4
7.0
24
57
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
6.9
47
185
ZXE00
NOMESCO Finland
One hour or less
1.7
6.9
192
1349
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.9
6.9
40
145
R50.9
ICD-10 Finland
Fever, unspecified
2.2
6.9
73
366
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
6.9
83
440
A01
ICPC
Pain general/multiple sites
2.7
6.9
47
188
M03BX02
ATC
tizanidine; oral
1.7
6.8
284
2237
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
17.0
6.8
10
6
RS221
NOMESCO Finland
NA
7.3
6.7
15
21
W10
ICD-10 Finland
Fall on and from stairs and steps
3.4
6.7
31
96
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
6.7
40
148
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
6.7
58
264
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.4
6.7
58
264
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
6.7
67
325
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
22.9
6.7
9
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.2
6.7
24
60
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.0
6.7
25
65
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
6.7
138
887
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
6.6
30
92
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
6.5
48
199
F43.29
ICD-10 Finland
Adaptation disorder UNS
5.5
6.5
18
34
R33
ICD-10 Finland
Retention of urine
2.7
6.5
43
170
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
6.5
113
686
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.8
6.5
20
43
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.0
6.5
24
62
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.2
6.5
32
105
R55
ICD-10 Finland
Syncope and collapse
2.3
6.5
61
289
G95.1
ICD-10 Finland
Vascular myelopathies
70.8
6.4
7
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
6.4
48
202
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.5
6.4
21
48
N06AA09
ATC
amitriptyline; systemic
2.3
6.4
58
269
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.7
6.4
15
23
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
8.3
6.4
13
16
109
Kela drug reimbursment
Multiple sclerosis
11.2
6.3
11
10
JN4BD
NOMESCO Finland
Extensive body CT
2.4
6.3
55
250
N02BE01
ATC
paracetamol; systemic, rectal
1.8
6.3
399
3503
P99
ICPC
Psychological disorders other
4.9
6.3
19
40
H53.2
ICD-10 Finland
Diplopia
3.9
6.3
24
64
G83.8
ICD-10 Finland
Other specified paralytic syndromes
+∞
6.3
6
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.2
6.2
31
102
L01
ICPC
Neck symptom/complaint
2.1
6.2
70
359
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.3
6.1
29
93
R53
ICD-10 Finland
Malaise and fatigue
1.9
6.1
100
595
N29
ICPC
Neurological sympt/complt other
5.3
6.1
17
33
M89.0
ICD-10 Finland
Algoneurodystrophy
10.2
6.1
11
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
6.1
35
127
J01DA01
ATC
[U] cefalexin; systemic
1.6
6.0
290
2339

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
257
1276
2.94
32.92
3.0
2.1
u/l
200.6
245.2
0.27
250
1212
(3018677) aPTT in Platelet poor plasma by Coagulation assay
161
659
3.06
28.63
7.1
1.8
s
29.6
29.6
0.03
156
641
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
38
49
8.27
27.99
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
36
46
8.32
26.69
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
28
26
11.31
26.19
1.1
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
47
86
5.89
25.05
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
315
1910
2.57
24.96
6.9
5.4
mmol/l
1.2
1.2
1.21
292
1741
(3023368) Bacteria identified in Blood by Culture
222
1146
2.60
24.69
5.5
4.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
379
2525
2.70
24.41
6.1
4.4
mmol/l
6.8
6.7
0.26
371
2356
(3016018) Differential panel - Cerebral spinal fluid
30
34
9.29
24.39
1.4
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
89
288
3.50
22.99
2.5
2.4
—
15.4
—
0
16
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
43
7.85
22.72
1.2
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
82
255
3.61
22.49
1.4
1.3
—
40.6
—
0
17
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
329
2104
2.45
22.22
7.7
6.4
mmol/l
1.2
1.2
0.07
289
1792
(3044640) Blood type and Crossmatch panel - Blood
241
1345
2.43
22.09
3.3
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
197
1019
2.47
21.18
3.2
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
329
2139
2.39
20.89
9.3
5.6
e9/l
0.6
0.6
2.41
289
1868
(3006315) Basophils [#/volume] in Blood
329
2151
2.36
20.44
9.3
5.6
e9/l
0.0
0.0
0.55
291
1882
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
23
23
10.40
20.39
1.2
1.0
u/l
1.5
1.1
—
9
11
(3024561) Albumin [Mass/volume] in Serum or Plasma
290
1815
2.30
19.73
5.0
4.6
g/l
35.1
35.7
1.05
276
1703
(3013115) Eosinophils [#/volume] in Blood
334
2224
2.32
19.51
10.4
5.9
e9/l
0.2
0.2
0.29
296
1980
(42870588) Differential panel, method unspecified - Blood
243
1418
2.30
19.48
10.2
5.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
335
2240
2.31
19.28
6.4
6.3
umol/l
10.1
11.2
1.48
319
2128
(3032080) INR in Blood by Coagulation assay
274
1707
2.23
18.45
7.2
8.9
inr
1.2
1.2
0.75
55
493
(3019198) Lymphocytes [#/volume] in Blood
328
2202
2.25
18.30
9.4
5.6
e9/l
2.0
1.9
0.21
293
1961
(3019069) Monocytes/100 leukocytes in Blood
308
2022
2.22
18.08
10.2
5.9
%
8.7
8.6
0.31
296
1904
(40758558) Short blood count panel - Blood
197
1082
2.29
17.92
10.0
6.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
310
2047
2.21
17.85
9.5
5.6
%
59.6
57.3
2.65
298
1928
(3023410) Appearance of Cerebral spinal fluid
29
46
6.61
17.73
1.4
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
306
2015
2.20
17.68
9.8
5.7
%
2.6
2.8
1.18
294
1883
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
43
99
4.63
17.65
1.4
1.2
e6/l
5.8
12.7
0.45
35
79
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
43
99
4.63
17.65
1.4
1.3
e6/l
286.9
123.8
0.29
36
82
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
252
1547
2.18
17.27
5.0
3.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
298
1957
2.17
17.15
9.7
5.7
%
0.7
0.7
0.15
285
1832
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
147
723
2.42
17.13
4.2
2.5
e6/l
1.2
1.0
0.26
79
403
(3002030) Lymphocytes/100 leukocytes in Blood
310
2070
2.17
17.06
9.9
5.8
%
25.8
27.9
2.68
296
1943
(3030467) Casts [#/volume] in Urine by Automated count
208
1189
2.22
16.99
4.7
3.0
e6/l
0.5
0.5
0.16
166
892
(4027681)
22
27
8.45
16.74
1.4
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
70
238
3.23
16.53
1.9
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
20
9.81
16.19
1.5
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
200
1148
2.18
15.97
4.7
2.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
24
8.62
15.47
1.4
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
350
2510
2.13
15.25
14.0
9.1
e9/l
4.4
4.1
1.90
310
2216
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
137
687
2.33
15.06
4.7
2.7
e6/l
3.3
2.4
0.53
69
368
(3018095) Leukocytes [#/volume] in Urine
242
1527
2.06
14.80
6.2
3.6
e6/l
319.1
104.0
0.47
177
1081
(3003396) Base excess in Arterial blood by calculation
104
464
2.54
14.77
6.1
7.2
mmol/l
0.4
1.2
1.28
86
366
(3000991) Gas panel - Venous blood
81
319
2.81
14.73
8.1
7.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
136
686
2.31
14.71
2.1
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
209
1264
2.07
14.21
4.4
3.7
ph
7.4
7.4
0.51
29
241
(3020630) Protein [Mass/volume] in Serum or Plasma
81
326
2.75
14.11
2.3
3.2
g/l
67.1
67.1
0.02
74
293
(3026008) Bacteria identified in Urine by Culture
216
1340
2.02
13.55
4.5
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
210
1299
2.01
13.20
5.1
3.1
e6/l
32.5
121.6
1.05
165
1002
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
101
471
2.41
12.94
2.0
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
47
5.53
12.88
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
27
7.26
12.78
1.4
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
128
664
2.22
12.77
7.0
3.2
mmol/l
0.8
0.8
0.40
115
626
(3013707) Erythrocyte sedimentation rate by Westergren method
412
3248
2.15
12.65
5.1
4.0
mm/h
14.1
11.8
2.12
388
2991
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
54
186
3.12
12.42
1.9
2.1
u/l
40.8
39.2
0.24
49
163
(3014576) Chloride [Moles/volume] in Serum or Plasma
106
514
2.32
12.40
6.6
6.2
mmol/l
104.3
103.9
0.35
106
498
(3003458) Phosphate [Moles/volume] in Serum or Plasma
110
543
2.29
12.33
8.3
4.8
mmol/l
1.0
1.0
0.02
99
499
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
259
1752
1.92
12.30
2.3
1.9
pmol/l
89.3
95.3
1.56
149
920
(3005719) IgG [Mass/volume] in Serum or Plasma
78
333
2.57
12.03
3.2
2.4
g/l
9.9
10.4
0.62
70
304
(3037467) Urinalysis macro (dipstick) panel - Urine
384
2981
2.01
11.85
6.3
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
99
476
2.32
11.77
2.1
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
107
535
2.25
11.59
26.8
21.5
inr
1.3
1.3
—
10
74
(3000850) Epithelial cells [#/volume] in Urine
153
880
2.03
11.53
3.2
2.6
e6/l
7.8
5.3
1.09
139
775
(3042936) Bacteria identified in Isolate by Culture
121
638
2.16
11.48
3.2
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
24
7.28
11.48
1.4
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
103
509
2.27
11.47
2.2
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
288
2051
1.87
11.36
4.7
3.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
41
126
3.44
11.32
3.3
3.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
141
799
2.04
11.01
6.6
3.5
ng/l
332.1
251.3
0.14
114
606
(3019309) Folate [Moles/volume] in Red Blood Cells
141
801
2.03
10.92
1.7
1.7
nmol/l
1058.7
1202.5
1.15
108
613
(3037522) Nuclear Ab [Titer] in Serum
112
584
2.16
10.89
1.6
1.3
titre
451.2
516.0
0.26
25
139
(3026782) Osmolality of Urine
146
847
1.99
10.63
3.7
2.7
mosm/kgh2o
567.8
562.5
0.11
130
723
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
308
2.50
10.55
1.8
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
165
1003
1.93
10.46
4.5
3.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
94
464
2.24
10.44
7.3
4.2
u/l
253.5
242.3
0.26
88
442
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
411
3340
1.98
10.16
9.7
7.5
u/l
78.2
77.8
0.09
399
3124
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
13
9.42
9.90
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
13
9.42
9.90
1.3
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
111
3.40
9.90
26.2
2.3
u/ml
0.3
0.4
0.26
16
60
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
239
1664
1.79
9.64
4.6
3.6
ng/l
41.7
40.7
0.03
176
1160
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
14
8.74
9.38
1.4
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
14
8.74
9.38
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
63
275
2.46
9.22
2.3
2.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
79
383
2.25
9.12
3.0
2.2
u/l
33.3
35.0
0.12
72
327
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
24
6.40
9.03
1.4
1.2
mmol/l
1.8
1.8
0.03
15
24
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
7
18.98
8.97
1.4
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
247
1767
1.74
8.84
2.7
2.3
nmol/l
74.7
76.8
0.43
224
1580
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
114
3.21
8.83
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
210
1449
1.74
8.46
3.4
3.3
mmol/l
2.4
2.4
0.20
183
1281
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
45
4.58
8.43
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
65
300
2.33
8.40
1.6
1.4
—
—
—
0
0
(3012544) pH of Venous blood
78
395
2.14
8.06
5.2
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
76
382
2.15
8.00
5.3
3.2
mmol/l
1.7
2.1
0.30
67
290
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
144
2.84
7.95
2.0
2.6
g/l
2.9
3.1
0.67
34
112
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
150
957
1.79
7.84
3.8
1.7
mg/l
1.2
1.2
0.03
117
755
(1761868) Lipid panel - Serum or Plasma
94
1563
0.52
7.80
2.7
2.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
71
3.64
7.78
1.5
1.3
u/ml
108.5
107.0
—
6
13
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
118
3.01
7.73
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
40
4.62
7.70
1.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
68
3.65
7.50
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
37
4.71
7.45
2.3
1.8
e9/l
1.9
1.0
—
9
17
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
156
2.69
7.37
2.0
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
156
2.69
7.37
2.0
2.5
g/l
7.5
7.5
0.11
34
115
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
156
2.69
7.37
2.0
2.5
g/l
3.8
3.7
0.19
33
109
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
69
3.59
7.35
1.3
1.2
u/ml
2.2
2.7
—
6
22
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
20
6.11
6.93
1.4
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
105
2.97
6.74
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
14
7.26
6.72
1.5
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
25
79
3.27
6.65
1.6
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
12
21
5.82
6.61
1.1
1.3
nmol/l
139.7
154.4
0.36
12
21
(3035350) Ketones [Presence] in Urine by Test strip
277
2152
1.59
6.51
4.6
3.6
estimate
0.0
0.0
0.00
39
403
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
25
81
3.19
6.39
1.6
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
159
1085
1.66
6.33
2.5
2.0
mg/l
2.9
3.1
0.81
133
930
(3007164) IgA [Mass/volume] in Serum or Plasma
133
866
1.71
6.31
1.8
1.4
g/l
2.3
2.5
0.25
77
522
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
15
34
4.51
6.27
2.7
1.9
e6/l
1158.8
681.9
—
6
15
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
190
1359
1.62
6.26
3.2
2.4
u/l
56.2
56.9
0.06
173
1261
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
124
794
1.73
6.25
2.6
3.0
mmol/l
2.5
2.5
0.86
107
705
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
110
2.83
6.22
3.4
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
43
4.05
6.21
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
43
4.05
6.21
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
43
4.05
6.21
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
184
1311
1.61
6.14
3.9
3.1
mmol/l
8.2
7.6
0.75
160
1099
(3009261) Glucose [Presence] in Urine by Test strip
279
2191
1.57
6.12
4.7
3.7
estimate
0.0
0.0
0.50
39
387
(3015171) Extractable nuclear Ab [Units/volume] in Serum
39
165
2.47
6.12
1.2
1.2
u/ml
0.2
2.4
—
5
12
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
87
506
1.86
6.04
2.0
1.8
%
1.5
1.5
0.15
80
437
(3021601) Nitrite [Presence] in Urine by Test strip
276
2167
1.56
6.03
6.6
5.0
estimate
0.0
0.0
0.00
40
403
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
44
3.96
6.03
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
44
3.96
6.03
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
44
3.96
6.03
1.2
1.1
—
—
—
0
0
(4306422)
20
59
3.48
5.92
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
481
4352
1.99
5.81
26.5
13.6
mg/l
26.1
22.9
1.32
426
3436
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
116
743
1.72
5.80
1.4
1.3
iu/ml
18.9
37.6
2.78
35
241
(3021589) Normoblasts [#/volume] in Blood
249
1926
1.55
5.72
14.9
9.1
e9/l
0.0
0.0
0.41
202
1594
(3004789) Transferrin [Mass/volume] in Serum or Plasma
99
609
1.77
5.70
2.5
2.2
g/l
2.5
2.4
0.96
94
561
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
61
321
2.02
5.68
5.7
3.0
ng/l
255.8
195.5
0.32
52
292
(3028026) IgM [Mass/volume] in Serum or Plasma
54
272
2.10
5.65
2.4
1.7
g/l
2.9
1.7
0.40
46
250
(3023520) Reticulocytes [#/volume] in Blood
63
340
1.97
5.46
4.8
2.6
e9/l
64.1
70.0
0.82
45
268
(3017143) Hepatitis C virus Ab [Presence] in Serum
83
492
1.81
5.41
1.6
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
81
478
1.82
5.35
2.6
2.6
umol/l
6.9
8.0
0.25
65
411
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
74
3.06
5.32
1.3
1.2
u/ml
3.0
3.7
—
8
34
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
22
5.08
5.28
1.8
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
194
1442
1.54
5.22
4.4
3.3
u/l
31.8
31.7
0.03
187
1374
(3020682) Albumin/Creatinine [Ratio] in Urine
176
1285
1.55
5.12
4.0
4.0
mg/mmol
7.2
9.9
0.54
116
833
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
65
3.16
5.11
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
36
162
2.31
4.97
4.3
4.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
106
2.63
4.96
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
53
279
2.00
4.94
4.0
4.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
381
3290
1.54
4.88
4.3
3.9
pmol/l
14.7
14.8
0.24
356
2988
(3026493) Urate [Moles/volume] in Serum or Plasma
155
1117
1.54
4.72
3.3
2.7
umol/l
2945.2
6104.9
0.53
133
968
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
172
1269
1.52
4.70
4.7
3.0
ng/l
1221.2
1285.8
0.10
160
1079
(3044889) 12 lead EKG panel
352
3008
1.49
4.58
4.6
3.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
265
1.98
4.58
1.6
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
21
4.83
4.55
1.3
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
30
130
2.38
4.51
3.3
3.6
mmol/l
3.7
3.8
1.14
30
118
(3012516) Albumin [Mass/volume] in Urine
165
1216
1.51
4.51
3.4
3.2
mg/l
43.5
167.7
0.98
109
804
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
210
2.08
4.50
8.4
9.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
210
2.08
4.50
5.9
3.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
78
479
1.73
4.50
4.4
2.5
%
1.8
1.8
0.02
65
437
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
90
579
1.67
4.38
2.7
2.2
%
21.0
22.3
0.49
82
499
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
31
3.94
4.27
1.4
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
99
660
1.61
4.18
1.5
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
13
7.02
4.17
1.0
1.0
miu/ml
1746.7
1607.3
—
9
13
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
149
2.22
4.11
2.4
2.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
23
4.41
4.10
1.3
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
114
790
1.56
4.08
1.8
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
269
1.90
4.07
6.0
3.7
mmol/l
0.9
1.9
1.51
36
199
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
7
10.11
4.02
1.7
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
7
10.11
4.02
1.7
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
7
10.11
4.02
1.7
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
95
2.48
3.85
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
67
412
1.72
3.85
2.1
1.8
nmol/l
354.4
374.7
0.34
60
379
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
140
2.21
3.84
1.5
1.5
iu/ml
0.0
0.1
—
7
27
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
128
2.25
3.77
1.5
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
338
1.77
3.72
3.2
2.6
ml/min/173m2
70.3
67.0
0.21
21
144
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
12
6.75
3.68
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
85
2.53
3.67
1.7
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
85
2.53
3.67
1.7
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
56
2.91
3.66
4.7
3.7
—
4287.8
—
0
6
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
171
2.05
3.62
2.2
1.8
—
—
—
0
0
(4035726)
61
372
1.72
3.62
1.5
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
132
968
1.48
3.60
1.4
1.3
u/ml
0.7
1.5
2.15
31
254
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
40
214
1.94
3.60
2.4
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
60
366
1.72
3.55
2.9
2.4
ug/l
7.0
7.7
0.11
49
330
(3048689) Calprotectin [Mass/mass] in Stool
81
536
1.60
3.52
2.3
2.2
ug/g
177.1
128.6
0.28
63
421
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
39
209
1.93
3.50
2.9
2.3
%
0.7
0.7
0.03
39
204
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
36
3.39
3.49
1.8
1.4
e6/l
37970.0
25396.9
—
5
21
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
160
2.06
3.47
2.4
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
437
3986
1.51
3.47
5.6
4.7
mu/l
1.9
2.2
0.61
409
3636
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
42
3.15
3.39
1.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
213
1727
1.39
3.30
2.4
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
138
1037
1.44
3.30
1.9
1.5
nmol/l
19.9
21.2
0.50
123
886
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
143
2.09
3.27
3.4
3.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
220
0.31
3.26
1.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
66
2.63
3.24
1.5
1.4
—
—
—
0
0
(4198724)
7
11
6.43
3.19
2.1
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
39
216
1.87
3.19
2.9
2.3
%
1.6
1.2
1.40
39
216
(3028707) Methadone [Presence] in Urine by Screen method
17
67
2.59
3.15
8.2
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
443
4077
1.49
3.11
21.6
12.6
ml/min/173m2
84.8
81.4
2.41
404
3354
(3023199) Leukocytes [#/volume] in Pleural fluid
12
39
3.12
3.10
1.7
1.4
e6/l
1063.9
1644.1
—
7
26
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
81
2.39
3.02
1.5
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
40
3.05
2.99
1.0
1.1
u/ml
0.3
1.5
—
7
17
(3001122) Ferritin [Mass/volume] in Serum or Plasma
230
1913
1.35
2.96
3.2
2.6
ug/l
118.1
120.5
0.05
207
1767
(3000494) Fungus identified in Specimen by Culture
75
508
1.55
2.96
1.9
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
46
2.87
2.93
2.4
2.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
58
2.63
2.89
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
58
2.63
2.89
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
73
494
1.55
2.89
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
22
4.14
2.89
3.0
2.5
u/ml
403.8
799.5
—
9
22
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
13
5.44
2.87
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
41
2.97
2.87
2.5
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
53
333
1.66
2.84
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
31
3.27
2.78
1.8
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
42
249
1.74
2.78
2.5
3.4
pmol/l
4.5
4.6
0.34
37
216
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
78
2.35
2.77
1.5
1.2
u/ml
287.3
257.2
0.12
12
39
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
111
2.12
2.77
1.3
1.2
u/l
15.1
10.0
0.63
15
92
(3045414) Leukocytes [Presence] in Urine
32
176
1.87
2.70
1.8
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
30
162
1.90
2.68
2.9
2.6
—
—
—
0
0
(4062490)
12
43
2.83
2.66
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
43
2.83
2.66
2.1
2.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
61
2.50
2.64
1.3
1.2
nmol/l
0.5
0.6
0.36
15
55
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
51
324
1.63
2.63
3.7
3.3
ng/l
81.5
75.0
0.21
45
289
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
142
1.95
2.60
1.6
1.3
iu/l
44.1
23.7
1.41
19
125
(3035880) pH of Pleural fluid
8
20
4.04
2.57
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
391
0.49
2.57
2.0
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
81
2.26
2.56
1.7
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
143
1.94
2.55
2.1
2.0
u/l
132.4
5041.3
—
8
62
(3008536) Aspergillus sp Ab [Presence] in Serum
6
11
5.50
2.55
1.0
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
324
2875
1.32
2.52
4.2
3.1
u/l
51.9
47.9
0.40
307
2703
(3035320) C reactive protein [Mass/volume] in Body fluid
9
26
3.50
2.49
3.2
2.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
9
26
3.50
2.49
3.2
3.5
mu/l
38.6
18.7
—
9
26
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
97
718
1.43
2.48
1.4
1.3
u/ml
9.9
13.2
0.28
31
284
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.67
2.37
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
55
368
1.55
2.31
4.4
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
41
2.72
2.29
3.3
3.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
47
2.59
2.28
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
86
2.13
2.25
2.3
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
9
5.59
2.22
1.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
54
2.44
2.21
1.0
1.1
u/ml
0.1
3.0
—
8
14
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
54
2.44
2.21
1.2
1.3
nmol/l
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
48
2.53
2.20
4.0
3.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
48
2.53
2.20
1.0
1.0
u/ml
1.4
2.7
—
7
18
(3003434) Protein [Mass/volume] in Pleural fluid
12
48
2.53
2.20
1.5
1.6
g/l
32.9
30.4
0.24
12
43
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
68
2.24
2.13
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
43
2.59
2.11
1.4
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
24
414
0.56
2.09
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
248
1.62
2.05
1.4
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
15
4.03
2.04
3.0
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
15
4.03
2.04
1.8
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
50
2.43
2.04
2.1
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
114
898
1.34
2.01
1.6
1.7
pmol/l
69792063.8
7713560.2
0.42
96
739
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
73
534
1.42
2.01
9.9
7.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
9
32
2.84
2.01
20.7
13.0
nmol/l
770.8
855.5
—
9
32
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
16
3.78
1.94
1.2
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
16
3.78
1.94
1.2
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
99
1.95
1.92
1.6
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
78
582
1.40
1.92
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
136
1.80
1.90
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
307
2762
1.26
1.89
3.4
3.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
12
52
2.34
1.89
1.1
1.3
—
75.1
—
0
5
(4010399)
46
312
1.52
1.85
1.7
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
130
1.80
1.84
1.2
1.4
ug/g
356.5
291.5
0.94
14
76
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
17
3.56
1.84
1.7
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
17
3.56
1.84
1.2
2.0
—
—
—
0
0
(4268621)
12
53
2.29
1.82
2.3
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
23
3.07
1.80
1.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
23
3.07
1.80
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
23
3.07
1.80
1.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
23
3.07
1.80
1.1
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
60
2.20
1.79
1.8
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
71
529
1.39
1.77
1.3
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
18
3.36
1.75
2.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
103
1.88
1.74
1.8
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
103
1.88
1.74
8.2
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
30
2.69
1.73
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
58
419
1.43
1.72
4.8
4.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.68
3.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
55
2.21
1.68
1.4
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
140
1162
1.28
1.68
1.9
1.7
mmol/l
1.6
1.4
1.65
128
968
(3004616) Nuclear Ab [Presence] in Serum
12
56
2.17
1.62
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
70
2.03
1.60
1.1
1.1
u/ml
0.3
2.9
—
8
29
(40760888) Immunoglobulin light chains.free panel - Serum
17
92
1.88
1.57
3.2
5.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
423
3991
1.28
1.56
6.7
5.7
mmol/mol
40.4
39.9
0.51
402
3717
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
15
3.35
1.52
1.8
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
21
2.88
1.51
1.3
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
21
2.88
1.51
1.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
116
1.75
1.50
2.6
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
394
3693
1.25
1.50
35.4
17.7
g/l
330.7
332.5
3.57
394
3666
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
147
1.66
1.50
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
65
2.02
1.50
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
443
4212
1.29
1.48
5.0
4.5
mmol/l
6.0
6.0
0.60
413
3839
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
481
4627
1.37
1.47
15.7
10.2
u/l
26.7
25.9
0.37
472
4467
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
148
1.65
1.46
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
59
2.06
1.44
1.1
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
22
2.75
1.44
2.8
4.1
nmol/l
93.8
95.2
—
6
22
(21494890) Protein electrophoresis panel - 24 hour Urine
10
46
2.20
1.40
1.0
2.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
41
2.22
1.37
1.4
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
151
1.62
1.37
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
90
1.80
1.34
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
267
0.59
1.30
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
62
1.96
1.28
2.2
2.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
49
365
1.38
1.27
5.5
4.5
%
1.2
0.8
0.30
19
116
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
297
1.41
1.25
1.2
1.2
iu/ml
65.1
131.0
0.77
14
118
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
116
1.66
1.23
1.3
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
49
2.06
1.22
1.7
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
143
0.48
1.22
1.3
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
19
2.65
1.22
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(4024509)
8
37
2.18
1.22
1.5
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
26
2.32
1.19
1.7
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
26
2.32
1.19
1.7
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
64
1.89
1.19
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
64
1.89
1.19
1.8
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
94
1.72
1.18
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
140
1207
1.22
1.18
1.4
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
126
0.47
1.18
1.2
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
102
1.69
1.17
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
150
1.56
1.16
6.4
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
40
293
1.39
1.15
2.3
2.7
e9/l
5.0
4.1
1.60
31
230
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
20
2.51
1.15
1.6
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
20
2.51
1.15
1.6
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
151
1.55
1.13
6.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
151
1.55
1.13
6.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
151
1.55
1.13
6.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
38
277
1.40
1.13
4.0
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
116
987
1.22
1.11
5.4
3.8
kg/l
1.0
1.0
0.39
14
136
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
41
1.97
1.09
1.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.97
1.09
1.1
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.97
1.09
1.1
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
472
4564
1.28
1.08
20.9
13.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
56
438
1.31
1.08
3.8
3.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
271
1.39
1.08
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
135
1171
1.20
1.07
5.3
3.8
estimate
0.0
0.0
0.50
38
397
(3020491) Glucose [Moles/volume] in Blood
7
33
2.14
1.06
1.9
2.0
mmol/l
7.6
6.5
—
7
25
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
33
2.14
1.06
1.1
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
46
1.97
1.04
1.6
1.8
ug/l
24.1
16.0
—
9
46
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
60
1.85
1.03
1.2
1.0
u/ml
1.0
4.3
—
6
32
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
47
1.93
1.02
2.2
3.4
nmol/l
2.3
3.8
—
9
47
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
9
48
1.89
1.01
1.1
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
35
2.01
1.00
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
23
2.18
0.98
1.0
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
108
1.59
0.97
1.3
1.8
iu/l
3.1
5.6
—
5
31
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
36
1.96
0.97
1.1
1.3
u/l
152.3
287.4
—
7
36
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
118
0.50
0.95
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
118
0.50
0.95
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
118
0.50
0.95
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
118
0.50
0.95
1.0
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
109
1.58
0.94
2.0
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
150
1.49
0.94
3.4
3.6
g/l
0.5
0.2
—
10
61
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
37
1.90
0.94
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
44
340
1.32
0.94
5.8
4.7
%
0.3
0.2
0.15
16
104
(3051651) Icteric interference index of Serum or Plasma
6
27
2.24
0.93
3.8
3.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
27
2.24
0.93
1.3
1.4
—
—
—
0
0
(3036603) Volume of Urine
6
27
2.24
0.93
1.3
1.7
—
1858.0
—
0
5
(3016879) Cocaine [Presence] in Urine
21
142
1.50
0.93
7.0
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
10
55
1.83
0.92
1.6
2.9
mg/l
29.2
22.8
—
5
18
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
118
1.54
0.92
7.4
1.4
—
—
—
0
0
(4034850)
21
143
1.49
0.91
9.0
11.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
79
1.66
0.88
1.3
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
56
1.80
0.88
2.0
2.2
u/ml
3.5
75.9
—
10
51
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
187
1696
1.16
0.86
5.0
3.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
31
1.95
0.84
1.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
57
1.77
0.84
2.2
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
223
1.37
0.83
1.0
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
42
330
1.30
0.82
5.5
4.4
%
0.9
0.4
0.37
12
85
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
32
1.88
0.82
1.5
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
47
1.71
0.81
3.8
2.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
41
323
1.29
0.79
5.8
4.7
%
0.1
0.1
0.13
14
91
(3015183) Erythrocyte sedimentation rate
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
413
4270
0.86
0.76
5.1
4.3
mmol/l
1.4
1.5
5.86
389
3939
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
53
1.71
0.75
7.7
3.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
75
1.61
0.75
1.8
1.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
24
2.09
0.74
2.8
2.0
—
—
—
0
0
(3013512) EKG study
141
1266
1.15
0.74
5.0
3.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
60
1.68
0.72
1.1
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
12
76
1.59
0.72
2.5
2.9
nmol/l
0.7
0.8
—
7
62
(1002224) Polysomnography panel
25
186
1.36
0.71
1.1
1.1
—
—
—
0
0
(4146454)
7
41
1.72
0.70
2.4
2.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
61
1.65
0.69
1.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
61
1.65
0.69
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
405
0.78
0.67
1.3
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
18
128
1.42
0.66
1.2
1.2
—
634.0
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
70
1.58
0.65
1.1
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
62
1.62
0.65
1.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
62
1.62
0.65
1.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
62
1.62
0.65
1.1
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
89
784
1.16
0.61
1.9
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
106
1.43
0.58
2.2
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
176
1.32
0.57
1.2
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
110
990
1.14
0.57
5.0
4.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
82
1.47
0.54
1.9
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
61
1.48
0.54
2.6
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
66
1.52
0.53
1.3
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
97
0.61
0.52
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
97
0.61
0.52
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
100
0.60
0.52
1.2
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
40
1.51
0.51
1.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
41
1.47
0.50
1.8
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
418
4284
0.89
0.50
5.2
4.4
mmol/l
4.5
4.7
3.91
395
3972
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
67
1.50
0.50
1.6
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
449
1.18
0.48
3.1
4.4
ug/l
4.6
30.8
0.88
41
383
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
514
0.84
0.47
1.8
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
68
1.48
0.47
1.4
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
2.1
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
31
1.62
0.43
4.2
1.5
%
11.5
11.2
—
5
31
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
70
1.44
0.42
1.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
96
1.36
0.42
1.4
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
3.2
—
216.9
—
0
15
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
1.7
—
0
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
59
1.36
0.41
2.0
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
71
1.42
0.39
1.4
2.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
794
1.11
0.38
2.6
2.9
ug/l
0.7
0.8
0.55
62
512
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
107
1.32
0.37
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
126
0.71
0.35
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
218
1.20
0.35
5.3
3.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
88
0.68
0.33
1.5
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
46
1.31
0.33
2.3
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
239
1.18
0.32
1.3
1.3
—
—
—
0
0
(44806118)
7
53
1.32
0.31
3.3
1.6
—
—
—
0
0
(44790047)
7
53
1.32
0.31
3.3
1.6
—
—
—
0
0
(44790048)
7
53
1.32
0.31
3.3
1.6
—
—
—
0
0
(44790049)
7
53
1.32
0.31
3.3
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
367
0.86
0.30
4.6
3.7
—
—
—
0
0
(3000492) Spirometry study
48
430
1.13
0.30
2.0
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.5
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
81
0.74
0.24
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
39
1.28
0.23
7.8
3.1
u/ml
35.5
56.7
—
5
39
(3021901) Oxygen saturation in Capillary blood
10
79
1.27
0.22
2.0
2.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.5
—
4.2
—
0
5
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
407
4126
0.94
0.20
4.6
3.9
mmol/l
1.4
1.3
3.30
380
3789
(3041096) Erythrocytes [Presence] in Urine by Automated
116
1214
0.94
0.20
4.3
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
433
4378
0.94
0.18
5.6
4.9
mmol/l
2.6
2.7
2.38
408
4032
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
60
1.17
0.18
1.3
1.1
—
15.9
—
0
5
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
92
1.20
0.16
2.5
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
149
1.15
0.16
1.2
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
401
3964
1.05
0.15
31.7
14.4
%
38.8
39.9
1.78
311
2878
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
16
181
0.88
0.14
2.7
1.7
mg/l
3.5
3.4
0.01
11
132
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
58
550
1.06
0.13
4.6
4.4
%
32.0
32.1
0.02
43
364
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
267
1.09
0.13
2.1
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
41
435
0.94
0.11
1.5
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
53
505
1.05
0.11
2.1
2.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
107
1102
0.96
0.10
3.4
4.3
%
20.0
21.1
0.38
47
505
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
232
1.08
0.10
4.8
2.9
e6/l
0.3
0.2
0.39
25
226
(3002523) Influenza virus A Ag [Presence] in Specimen
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
136
1380
0.98
0.05
4.1
4.8
ug/l
2.2
2.6
0.55
123
1233
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
47
458
1.03
0.03
2.0
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
161
1.06
0.03
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
122
1.07
0.02
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
122
1.07
0.02
7.4
4.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
153
1.05
0.01
1.5
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
215
0.98
0.00
1.4
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
215
1.02
0.00
1.6
1.8
—
—
—
0
0
(4094501)
11
113
0.97
0.00
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
113
0.97
0.00
1.3
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
113
0.97
0.00
1.3
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
69
1.01
0.00
3.0
2.6
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
17.8
—
0
7
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
63
0.95
0.00
3.0
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
67
670
1.00
0.00
1.7
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
24.2
—
0
9
(3035285) Chloride [Moles/volume] in Venous blood
7
70
1.00
0.00
3.0
2.5
mmol/l
108.6
105.5
—
7
70
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
8.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
70
1.00
0.00
3.0
2.5
mmol/l
4.1
4.0
—
7
70
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.5
—
83.7
—
0
8
(3006576) Bicarbonate [Moles/volume] in Blood
0
9
0.00
0.00
0.0
5.9
—
25.2
—
0
9
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
2.7
—
6088.4
—
0
9
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
87
0.92
0.00
1.3
3.0
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MONOPLE and mortality.

Females

Parameter HR [95% CI] p-value
G6_MONOPLE 2.189 [1.82, 2.63] < 0.001
Birth year 0.996 [0.99, 1.0] 0.326

During the follow-up period (1.1.1998 — 31.12.2019), 462 out of 1605 females with G6_MONOPLE died.

Males

Parameter HR [95% CI] p-value
G6_MONOPLE 2.165 [1.83, 2.56] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 563 out of 1664 males with G6_MONOPLE died.

Mortality risk

Mortality risk for people of age

years, who have G6_MONOPLE.

N-year risk Females Males
1 0.199% 0.476%
5 1.338% 2.423%
10 3.21% 5.915%
15 6.149% 11.001%
20 10.489% 18.359%

Relationships between endpoints

↥

Index endpoint: G6_MONOPLE – Monoplegia

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data